Is Bristol-Myers Squibb's Stock Rally Justified? Bull Vs. Bear Analysts On Q2 Earnings - Bristol-Myers Squibb ( NYSE:BMY )
Bristol-Myers Squibb Co BMY on Friday reported upbeat second-quarter results. The report came amid an exciting earnings season. Here are some key analyst takeaways. Analyst Carter Gould downgraded the rating to Underweight, while maintaining the price target at $41.
https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40016597/is-bristol-myers-squibbs-stock-rally-justified-bull-vs-bear-analysts-on-q2-earnings